跳至主要内容
临床试验/NCT00534339
NCT00534339撤回不适用

EasyBand GOAL Trial

Allergan Medical2 个研究点 分布在 2 个国家开始时间: 2010年12月最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Percent excess weight loss (%EWL)

研究概览

简要总结

Safety, effectiveness, and performance of Allergan's EasyBand telemetrically adjustable gastric banding device for the treatment of morbidly obese patients.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Minimum 3 year history of morbid obesity with documented failure of conservative, non-surgical means of weight reduction within 1 year prior to the screening visit;
  • BMI >/= 40 kg/m2, or BMI >/= 35 kg/m2 and </= 40 kg/m2 with one or more significant medical conditions related to obesity;
  • Candidate for surgical weight loss intervention

排除标准

  • Previous surgical treatment of obesity;
  • Patient already implanted with a device sensitive to radiofrequency emissions (implantable pacemaker, implantable defibrillator, etc);
  • Physical or emotional conditions that may prohibit surgery

结局指标

主要结局

Percent excess weight loss (%EWL)

时间窗: 5 years

次要结局

未报告次要终点

研究者

申办方类型
Industry

研究点 (2)

Loading locations...

相似试验

EasyBand GOAL Trial | 临床试验